Literature DB >> 11466695

Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling.

D Tackels-Horne1, M D Goodman, A J Williams, D J Wilson, T Eskandari, L M Vogt, J F Boland, U Scherf, J G Vockley.   

Abstract

BACKGROUND: The characterization of differentially expressed genes between cancerous and normal tissues is an important step in the understanding of tumorigenesis. Global gene expression profiling with microarrays has now offered a powerful tool to measure the changes of thousands of genes in any carcinoma tissues in an effort to identify these key disease-related genes. To compare the gene expression of a primary liver carcinoma, metastatic carcinoma to the liver, and normal liver, the authors analyzed tissue from six primary hepatocellular carcinomas (HCCs), five colorectal adenocarcinoma metastases to the liver, and eight normal livers.
METHODS: Samples were processed from total RNA to fragmented cRNA and hybridized onto Affymetrix GeneChip(R) expression arrays. Analyses were performed to determine the consensus pattern of gene expression for primary liver carcinoma, metastatic liver carcinoma, and normal liver tissue and their changes in expression level.
RESULTS: In hepatocellular carcinoma, 842 genes were overexpressed, and 393 genes were underexpressed in comparison with genes of normal liver tissue. Of note, 7 of the 20 most increased identified known genes previously have been associated with liver carcinoma or other types of cancers. The 13 additional identified genes until now have not previously shown strong association with cancers. Furthermore, the authors identified 42 genes and 24 expressed sequence tags that are expressed at a significant level in both HCC and metastastic tumors, presenting a list of marker genes indicative of cancerous liver tissue.
CONCLUSIONS: In this study, genes that can be involved in the production of and maintenance of hepatic carcinomas were identified. These data offer new insight into genes that are potentially important in the pathogenesis of liver carcinoma, as well as additional targets for new strategies for cancer therapy and treatment. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11466695     DOI: 10.1002/1097-0142(20010715)92:2<395::aid-cncr1335>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma.

Authors:  Rong-Rong Wei; Mei-Yin Zhang; Hui-Lan Rao; Heng-Ying Pu; Hui-Zhong Zhang; Hui-Yun Wang
Journal:  Med Oncol       Date:  2011-12-07       Impact factor: 3.064

2.  Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.

Authors:  Xiao-Qian Chen; Juan-Ru He; Hui-Yun Wang
Journal:  Med Oncol       Date:  2011-10-11       Impact factor: 3.064

3.  Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays.

Authors:  Kulkarni Prakash; Gregorio Pirozzi; Michael Elashoff; William Munger; Iwao Waga; Rajiv Dhir; Yoshiyuki Kakehi; Robert H Getzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 4.  Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression.

Authors:  Sergey A Krupenko; Natalia I Krupenko
Journal:  Chem Biol Interact       Date:  2019-02-20       Impact factor: 5.192

5.  Expression of liver cancer associated gene HCCA3.

Authors:  Z X Wang; G F Hu; H Y Wang; M C Wu
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

6.  Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents.

Authors:  Geoff W Birrell; James A Brown; H Irene Wu; Guri Giaever; Angela M Chu; Ronald W Davis; J Martin Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

7.  Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.

Authors:  Albert Y Lin; Mei-Sze Chua; Yoon-La Choi; William Yeh; Young H Kim; Raymond Azzi; Gregg A Adams; Kristin Sainani; Matt van de Rijn; Samuel K So; Jonathan R Pollack
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

8.  Functional genomics analysis of low concentration of ethanol in human hepatocellular carcinoma (HepG2) cells. Role of genes involved in transcriptional and translational processes.

Authors:  Francisco Castaneda; Sigrid Rosin-Steiner; Klaus Jung
Journal:  Int J Med Sci       Date:  2006-12-21       Impact factor: 3.738

9.  The hepatic transcriptome in human liver disease.

Authors:  Nicholas A Shackel; Devanshi Seth; Paul S Haber; Mark D Gorrell; Geoffrey W McCaughan
Journal:  Comp Hepatol       Date:  2006-11-07

10.  Knockout of Putative Tumor Suppressor Aldh1l1 in Mice Reprograms Metabolism to Accelerate Growth of Tumors in a Diethylnitrosamine (DEN) Model of Liver Carcinogenesis.

Authors:  Natalia I Krupenko; Jaspreet Sharma; Halle M Fogle; Peter Pediaditakis; Kyle C Strickland; Xiuxia Du; Kristi L Helke; Susan Sumner; Sergey A Krupenko
Journal:  Cancers (Basel)       Date:  2021-06-28       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.